Armata Pharmaceuticals, Inc. (ARMP) Insider Ownership

Historic Insider Ownership Trends

ARMP's three largest insider shareholders as of March 23, 2026 are Inc. Innoviva, (Director, 16.37Mn shares), Deborah Birx (Chief Executive Officer, 217.38K shares), Pierre Kyme (Chief Business Officer, 10.49K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Inc. Innoviva, 0 16,365,969 01 Apr, 2022
Deborah Birx Chief Executive Officer 212,458 0 17 Mar, 2026
Richard Rychlik Corporate Controller And Pfo 10,000 0 18 Mar, 2024
Pierre Kyme Chief Business Officer 9,461 0 17 Mar, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
14 Mar, 2026 Deborah Birx Common Stock D 4,919 $10.54 212,458 D F
14 Mar, 2026 Pierre Kyme Common Stock D 1,030 $10.54 9,461 D F
09 Mar, 2026 Sarah J. Schlesinger Stock Options (Right to Buy) A 25,640 $0.00 25,640 D A
09 Mar, 2026 Pierre Kyme Stock Options (Right to Buy) A 183,142 $0.00 183,142 D A
09 Mar, 2026 Todd C. Peterson Stock Options (Right to Buy) A 25,640 $0.00 25,640 D A
09 Mar, 2026 Joseph M Patti Stock Options (Right to Buy) A 25,640 $0.00 25,640 D A
09 Mar, 2026 Kostas D Odysseas Stock Options (Right to Buy) A 25,640 $0.00 25,640 D A
09 Mar, 2026 Deborah Birx Stock Options (Right to Buy) A 421,226 $0.00 421,226 D A
09 Mar, 2026 Jules Haimovitz Stock Options (Right to Buy) A 25,640 $0.00 25,640 D A
09 Mar, 2026 Robin Kramer Stock Options (Right to Buy) A 25,640 $0.00 25,640 D A
09 Mar, 2026 David Duane House Stock Options (Right to Buy) A 109,885 $0.00 109,885 D A
10 Jul, 2025 Deborah Birx Common Stock D 13,637 $2.27 217,377 D F
14 Mar, 2025 Pierre Kyme Common Stock D 1,027 $1.95 10,491 D F
05 Feb, 2025 Sarah J. Schlesinger Stock Options (Right to Buy) A 54,343 $0.00 54,343 D A
05 Feb, 2025 Robin Kramer Stock Options (Right to Buy) A 54,343 $0.00 54,343 D A
05 Feb, 2025 Joseph M Patti Stock Options (Right to Buy) A 54,343 $0.00 54,343 D A
05 Feb, 2025 Pierre Kyme Stock Options (Right to Buy) A 100,000 $0.00 100,000 D A
05 Feb, 2025 Jules Haimovitz Stock Options (Right to Buy) A 54,343 $0.00 54,343 D A
05 Feb, 2025 Kostas D Odysseas Stock Options (Right to Buy) A 54,343 $0.00 54,343 D A
05 Feb, 2025 David Duane House Stock Options (Right to Buy) A 25,000 $0.00 25,000 D A